Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations. Climacteric. 2009 Sep 1:1-11.
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2010-03-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://endojournals.ru/index.php/omet/article/view/5291 |
Similar Items
-
The role of dydrogesterone in habitual miscarriage
by: E. S. Polushkina, et al.
Published: (2020-04-01) -
ASSOCIATION BETWEEN RECORD GYNECOLOGICAL-OBSTETRICS AND CLIMACTERIC SYMPTOMS
by: Estela Rodrigues Paiva Alves, et al.
Published: (2013-12-01) -
Effect of Oral versus Vaginal Administration of Estradiol and Dydrogesterone on the Proliferative and Secretory Transformation of Endometrium in Patients with Premature Ovarian Failure and Preparing for Assisted Reproductive Technology
by: Feng W, et al.
Published: (2021-04-01) -
Dydrogesterone in the treatment of the threatened and habitual miscarriage
by: N. K. Tetruashvili, et al.
Published: (2018-09-01) -
The use of 17β Estradiol gel and progestogen tablet for hormone replacement therapy (HRT) in menopause
by: Ali Baziad
Published: (2003-08-01)